Artelo Biosciences (ARTL) Current Assets (2014 - 2026)
Artelo Biosciences' Current Assets was $10.42 million in Q1 2026, up 654.1% from $1.38 million a year earlier.
Powered by 
Analysis
Artelo Biosciences (ARTL) Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Artelo Biosciences came in at $695,000, down 72.8% from FY2024.
- Current Assets has now declined for four consecutive years, with a five-year compound annual growth rate of -21.5% (FY2020 to FY2025).
- In earlier years, Current Assets was $2.56 million in FY2024 (-76.7%), $10.98 million in FY2023 (-40.1%), $18.32 million in FY2022 (-25.5%) and $24.61 million in FY2021.
- The Q1 2026 figure marks the highest quarterly Current Assets since Q4 2023.
- Compared with a year earlier, Current Assets was higher in 1 of the last eight quarters, with growth averaging 21.7%.
- The best year-over-year quarter for Current Assets over five years was Q1 2026 (growth of 654.1%); the worst was Q1 2025 (a decline of 83.1%).
- Per Business Quant data, ARTL's Current Assets in the three quarters before Q1 2026 was $695,000 (Q4 2025), $1.83 million (Q3 2025) and $2.23 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Artelo Biosciences | 49.32 Mn | 32.53 Mn | - | 4.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.37 Mn |
| Mar 31, 2026 | 10.42 Mn |
| Dec 31, 2025 | 695,000.00 |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 2.56 Mn |
| Sep 30, 2024 | 4.99 Mn |
| Jun 30, 2024 | 6.17 Mn |
| Mar 31, 2024 | 8.19 Mn |
| Dec 31, 2023 | 10.98 Mn |
| Sep 30, 2023 | 13.43 Mn |
| Jun 30, 2023 | 14.60 Mn |
| Mar 31, 2023 | 16.39 Mn |
| Dec 31, 2022 | 18.32 Mn |
| Sep 30, 2022 | 20.30 Mn |
| Jun 30, 2022 | 22.28 Mn |
| Mar 31, 2022 | 24.59 Mn |
| Nov 30, 2021 | 25.36 Mn |
| Aug 31, 2021 | 10.32 Mn |
API Access
Artelo Biosciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();